Citation Impact
Citing Papers
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Steroid‐related complications in the cyclosporine era
1994
Tacrolimus, a New Immunosuppressant—A Review of the Literature
1994
Delayed graft function in kidney transplantation
2004 Standout
INTERFERON-α-INDUCED ACUTE RENAL ALLOGRAFT REJECTION
1995
Patients on renal replacement therapy for 20 or more years: a clinical profile
2002
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
POSTTRANSPLANT DIABETES MELLITUS IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS: A REPORT OF THE NORTH AMERICAN PEDIATRIC RENAL TRANSPLANT COOPERATIVE STUDY (NAPRTCS)1
2001
Dextrans for targeted and sustained delivery of therapeutic and imaging agents
2000
The mechanism of action of the immunosuppressive drug FK-506
1989
Development of Diabetes Mellitus Following Kidney Transplantation: A Canadian Experience
2004
Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus
2002
Pharmacokinetics of tacrolimus in liver transplant patients*
1995
FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes
1991
Post-Transplant Diabetes Mellitus The Role of Immunosuppression
1997
A review of drug release mechanisms from nanocarrier systems
2017
Immunosuppressive Macrolides of the Type FK 506: A Novel Class of Topical Agents for Treatment of Skin Diseases?
1992
A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1
1997 Standout
Drug-Induced Acute Pancreatitis
1989
Post-Transplant Diabetes Mellitus in Renal Allograft Recipients: A Matched-Pair Control Study
1990
Clinically Significant Drug Interactions with Cyclosporin
1996
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
1989 Nature
Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR
1993
Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus
1991
SUPPRESSION OF ALLOGRAFT REJECTION WITH FK506
1990
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Tacrolimus
1993
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Skin Cancers after Organ Transplantation
2003 Standout
Induction of hepatic differentiation in embryonic stem cells by co-culture with embryonic cardiac mesoderm
2003 StandoutNobel
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
2000
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Rescue of Degradation‐Prone Mutants of the FK506‐Rapamycin Binding (FRB) Protein with Chemical Ligands
2007 StandoutNobel
Diabetes Mellitus after Kidney Transplantation in the United States
2003 Standout
Drug-Induced Acute Pancreatitis: An Evidence-Based Review
2007
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Clinical Pharmacokinetics of Tacrolimus
1995 Standout
Liver nonparenchymal cells involved in hyporesponsiveness induced by portal vein injection of alloantigen
2002
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
IN VIVO IMMUNOGENICITY OF PURIFIED ALLOGENEIC HEPATOCYTES IN A MURINE HEPATOCYTE TRANSPLANT MODEL1,2
1998
Acute Pancreatitis
1994 Standout
Function-Preserving Gastrectomy for Early Gastric Cancer
2013
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
The Use of Tacrolimus in Pediatric Liver Transplantation
1998
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
ISLET CELL DAMAGE ASSOCIATED WITH TACROLIMUS AND CYCLOSPORINE: MORPHOLOGICAL FEATURES IN PANCREAS ALLOGRAFT BIOPSIES AND CLINICAL CORRELATION1
1999
Gastric cancer
2020 Standout
Novel crosslinking methods to design hydrogels
2002 Standout
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
1992 StandoutNature
The effects of a new immunosuppressive agent, FK506, on the glomerular injury in rats with accelerated nephrotoxic serum glomerulonephritis
1990
Cyclosporin A—cyclophilin complex formation A model based on X‐ray and NMR data
1992 StandoutNobel
Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen
2000 Standout
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
1991 Standout
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Conformational polymorphism of cyclosporin A
1994 StandoutNobel
Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
2011 Standout
Symptom evaluation of long-term postoperative outcomes after pylorus-preserving gastrectomy for early gastric cancer
2007
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
2004 Standout
Cell migration, chimerism, and graft acceptance
1992 Standout
Effects of human soluble thrombomodulin on experimental glomerulonephritis
2002 StandoutNobel
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
1993 Standout
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver
2003 StandoutNobel
Clinical Outcome of Pylorus‐preserving Gastrectomy in Gastric Cancer in Comparison with Conventional Distal Gastrectomy with Billroth I Anastomosis
2008
Binding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C
1995 StandoutScienceNobel
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells
1995 StandoutScience
Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen.
1994
Mechanisms of Drug Release in Nanotherapeutic Delivery Systems
2015
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Tacrolimus
2000
Correlative imaging of ionic transport and electronic structure in nano Li0.5FePO4 electrodes
2019 StandoutNobel
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
1991 StandoutScience
Yeast global transcriptional regulators Sin4 and Rgr1 are components of mediator complex/RNA polymerase II holoenzyme.
1995 StandoutNobel
Effects of Immunosuppressive Agents on Glucose Metabolism
1995
Why do we reject a graft? Role of indirect allorecognition in graft rejection
1999
Alloantigen–induced specific immunological unresponsiveness
2001
Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs.
1995 StandoutNobel
Discovering High-Affinity Ligands for Proteins: SAR by NMR
1996 StandoutScience
The Hematopoietic Development of Dendritic Cells: A Distinct Pathway for Myeloid Differentiation
1996 StandoutNobel
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
2010 Standout
Inhibition of FKBP Rotamase Activity by Immunosuppressant FK506: Twisted Amide Surrogate
1990 Science
Naturstoffe als Sonden zum Studium zellulärer Funktionen – Untersuchungen von Immunophilinen
1992
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Works of T Hamashima being referenced
Long‐term prognosis of renal transplant surviving for over 10 yr, and clinical, renal and rehabilitation features of 20‐yr successes
1997
MEMBRANE-BOUND OR SOLUBLE TRUNCATED RTI.Aa RAT CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS INDUCE SPECIFIC ALLOIMMUNITY
1995
Combination Therapy of Tacrolimus (FK506) With Azathioprine and Steroids in Renal Transplant Recipients
1998
Effect of Cyclosporine on the Endocrine and Exocrine Pancreas in Kidney Transplant Recipients
1988
Synergistic interaction of 3 M KCl-extracted donor antigens (e-HAg) with cyclosporine or cyclosporine/sirolimus for prolongation of rat heart allograft survival
1995
EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITRO
1989
EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITRO
1989
THE EFFECTS OF PERIOPERATIVE PORTAL VENOUS INOCULATION WITH DONOR LYMPHOCYTES ON RENAL ALLOGRAFT SURVIVAL IN THE RAT
1990
INDUCTION OF TRANSPLNATATION TOLERANCE BY CHIMERIC DONOR/RECIPIENT CLASS I RT1.AA MOLECULES1,2
1996
Synthesis and pharmacokinetics of a novel macromolecular prodrug of Tacrolimus (FK506), FK506–dextran conjugate
1999
Postoperative clinical evaluation following pylorus-preserving gastrectomy.
2004
A new immunosuppressive agent, FK506, inhibits the expression of alloantigen-activated suppressor cells as well as the induction of alloreactivity.
1989
Esophagogastrostomy reconstruction after limited proximal gastrectomy.
2002